Evidence map›Paper›PMID 26371754›Full record

ArticlePloS one2015

Fibroblast-Derived Extracellular Matrices: An Alternative Cell Culture System That Increases Metastatic Cellular Properties.

Michael T Scherzer, Sabine Waigel, Howard Donninger, Vennila Arumugam, Wolfgang Zacharias, Geoffrey Clark, Leah J Siskind, Patricia Soucy, Levi Beverly

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Organoids technology in cancer research: from basic applications to advancedFrontiers in cell and developmental biology · 2025
    Review
  2. Article
  3. Engineered Biomaterials and Model Systems to Study YAP/TAZ in Cancer.ACS biomaterials science & engineering · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Michael T ScherzerJ. G. Brown Cancer Center, University of Louisville, Louisville, Kentucky, 40202, United States of America; Department of Bioengineering, University of Louisville, Louisville, Kentucky, 40202, United States of America.
Sabine WaigelJ. G. Brown Cancer Center, University of Louisville, Louisville, Kentucky, 40202, United States of America.
Howard DonningerJ. G. Brown Cancer Center, University of Louisville, Louisville, Kentucky, 40202, United States of America; Department of Medicine, University of Louisville, Louisville, Kentucky, 40202, United States of America.
Vennila ArumugamJ. G. Brown Cancer Center, University of Louisville, Louisville, Kentucky, 40202, United States of America.
Wolfgang ZachariasJ. G. Brown Cancer Center, University of Louisville, Louisville, Kentucky, 40202, United States of America; Department of Medicine, University of Louisville, Louisville, Kentucky, 40202, United States of America; Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, 40202, United States of America.
Geoffrey ClarkJ. G. Brown Cancer Center, University of Louisville, Louisville, Kentucky, 40202, United States of America; Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, 40202, United States of America.
Leah J SiskindJ. G. Brown Cancer Center, University of Louisville, Louisville, Kentucky, 40202, United States of America; Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, 40202, United States of America.
Patricia SoucyDepartment of Bioengineering, University of Louisville, Louisville, Kentucky, 40202, United States of America.
Levi BeverlyJ. G. Brown Cancer Center, University of Louisville, Louisville, Kentucky, 40202, United States of America; Department of Bioengineering, University of Louisville, Louisville, Kentucky, 40202, United States of America; Department of Medicine, University of Louisville, Louisville, Kentucky, 40202, United States of America; Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, 40202, United States of America.
University of Louisville · US

Funding

PILOT PROJECT PROGRAMP30GM106396 · NIGMS · UNIVERSITY OF LOUISVILLE · PI EATON, JOHN W · 2013 to 2017
$5.4M
Ubiquilins regulate EMT, migration and invasion of human lung cancerR01CA193220 · NCI · UNIVERSITY OF LOUISVILLE · PI BEVERLY, LEVI J · 2015 to 2019
$2.3M
Role of Ceramide-induced Kidney Cell Death in Acute Kidney InjuryR01DK093462 · NIDDK · UNIVERSITY OF LOUISVILLE · PI SISKIND, LEAH J · 2012 to 2016
$1.6M
The role of the Ras effector Nore1a in tumor suppressionR01CA133171 · NCI · UNIVERSITY OF LOUISVILLE · PI CLARK, GEOFFREY J. · 2010 to 2014
$1.3M
NCI NIH HHS R01 CA133171NCI NIH HHS R01CA133171NCI NIH HHS R01 CA193220NCI NIH HHS R01CA193220NIDDK NIH HHS R01 DK093462NIDDK NIH HHS R01DK093462NIGMS NIH HHS 1P30GM106396NIGMS NIH HHS P30 GM106396
6 · The paper itself

Abstract

Poor survival rates from lung cancer can largely be attributed to metastatic cells that invade and spread throughout the body. The tumor microenvironment (TME) is composed of multiple cell types, as well as non-cellular components. The TME plays a critical role in the development of metastatic cancers by providing migratory cues and changing the properties of the tumor cells. The Extracellular Matrix (ECM), a main component of the TME, has been shown to change composition during tumor progression, contributing to cancer cell invasion and survival away from the primary cancer site. Although the ECM is well-known to influence the fate of tumor progression, little is known about the molecular mechanisms that are affected by the cancer cell-ECM interactions. It is imperative that these mechanisms are elucidated in order to properly understand and prevent lung cancer dissemination. However, common in vitro studies do not incorporate these interactions into everyday cell culture assays. We have adopted a model that examines decellularized human fibroblast-derived ECM as a 3-dimensional substrate for growth of lung adenocarcinoma cell lines. Here, we have characterized the effect of fibroblast-derived matrices on the properties of various lung-derived epithelial cell lines, including cancerous and non-transformed cells. This work highlights the significance of the cell-ECM interaction and its requirement for incorporation into in vitro experiments. Implementation of a fibroblast-derived ECM as an in vitro technique will provide researchers with an important factor to manipulate to better recreate and study the TME.

Indexed as

Cell Culture TechniquesCell Line, TumorCell ProliferationEpithelial CellsExtracellular MatrixFibroblastsHumansLung NeoplasmsTumor Microenvironment

Identifiers

PMID26371754
PMCPMC4570771
OpenAlexW2177483881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.